Dr. Jean-Philippe Pignol, MD, PhD
Professor and Chair, Department of Radiation Oncology, Dalhousie University; Radiation Oncology Chief, Department of Radiation Oncology, Nova Scotia Health Authority
Adjunct Professor, Erasmus MC, Rotterdam; Adjunct Professor, TU Delft, Delft, The Netherlands
Breast cancers, brachytherapy, radiobiology, hadrontherapy, nanoparticles, medical physics, Monte Carlo simulation
Evaluating clinical benefit of new technologies
As breast cancer specialist my clinical research included several multicenter trials evaluating the benefit of breast Intensity Modulated Radiotherapy or hypofractionated regimens, and the development of a one-hour breast radioactive seeds brachytherapy. Physics and radiobiology researches included the evaluation of nanoparticle radiosensitization evaluating the sub-microscopic energy deposition with Monte Carlo simulation and the development of targeted nanoparticles carriers. In 2014 I joined Erasmus University in Rotterdam and the Technical University of Delft. As Medical Co-Director of HollandPTC, I supervised the development of one of the three protontherapy centre in The Netherlands.
What brought you to your current institution?
After 14 years in Ontario I worked as Chair of the Department of Radiation Oncology at Erasmus MC in Rotterdam. This is the largest academic centre in the country. In this capacity I supervised the development of HollandPTC, one of the 3 protontherapy facilities in The Netherlands. For familial reasons we decided to come back to Canada. During my time in Ontario I heard great things about Dalhousie and beautiful Nova Scotia. I also knew that the Department of Radiation Oncology at Dalhousie had a stellar Medical Physics team. Arriving here at a time of major redevelopment of the cancer program is a phenomenal opportunity to bring major biomedical companies in our field to invest in Nova Scotia.
Hometown: Strasbourg, France